Prior to administration of Tetanus Toxoid Adsorbed vaccine, health-care personnel should inform the parent, guardian, or adult patient the benefits and risks of immunization, and also inquire about the recent health status of the patient to be injected.

The health-care provider should inform the parent, guardian, or adult patient about the potential for adverse reactions that have been temporally associated with Tetanus Toxoid Adsorbed administration. The parent, guardian or adult patient should be instructed to report any serious adverse reactions to their health-care provider.

As part of the child's or adult's permanent immunization record, the date, lot number and manufacturer of the vaccine administered MUST be recorded.^8,9,10

IT IS EXTREMELY IMPORTANT WHEN THE PARENT, GUARDIAN, OR ADULT PATIENT RETURNS FOR THE NEXT DOSE IN THE SERIES, THE PARENT, GUARDIAN, OR ADULT PATIENT SHOULD BE QUESTIONED CONCERNING OCCURRENCE OF ANY SYMPTOMS AND/OR SIGNS OF AN ADVERSE REACTION AFTER THE PREVIOUS DOSE (SEE CONTRAINDICATIONS; ADVERSE REACTIONS SECTIONS).

The health-care provider should inform the parent, guardian, or adult patient of the importance of completing the immunization series.

The health-care provider should provide the Vaccine Information Materials (VIMs) which are required to be given with each immunization.

REFERENCES

8. CDC. Vaccine Adverse Event Reporting System – United States. MMWR 39: 730-733, 1990

9. CDC. National Childhood Vaccine Injury Act: requirements for permanent vaccination records and for reporting of selected events after vaccination. MMWR 37: 197-200, 1988

10. Food and Drug Administration. New reporting requirements for vaccine adverse events. FDA Drug Bull 18 (2), 16-18, 1988

Last reviewed on RxList: 1/13/2009
This monograph has been modified to include the generic and brand name in many instances.